What a week it was for the major averages. The meteoric rise would almost have to find perma-bears and “top callers” in dismay had they not left long positions in play until the markets showed actual signs of resistance and subsequent declines. The Dow Jones Industrial Average climbed 4.4% and the S&P 500 has rallied 4.2% through Friday for their…
S&P 500 RSI Most Overbought In 38 Years And The VIX Did What?
A financial market resource for the every-day investor and trader.
-
S&P 500 Brushes Off Mixed Data, Decelerating Earnings & Yield Curve
Seth Golden, , Research Reports, 0
When momentum develops, it can become a driving force greater than fundamentals and rational considerations. Such was the case...
-
Weekly Warm-up: Outlook Feedback and Consumer Update
Seth Golden, , Research Reports, 0
This week, we provide feedback to our 2022 Outlook—spoiler alert—there wasn’t as much as usual. Meanwhile, consumers are opening...
-
My Plans For Success In 2017 Continue To Involve VIX-Leveraged ETFs/ETNs
Seth Golden, , Research Reports, 0
In 2016, the Golden Capital Portfolio managed to achieve a 167% return on capital invested. Capital allocation was largely...
-
Weekly State of the Market: Credit Crunch Or Just Another Headwind?
Seth Golden, , Research Reports, 0
If you came to the markets in 2008, that you likely will relate everything since and to come to...
-
From Crisis to Resolve in 2019? Markets Favor The Latter
Seth Golden, , Research Reports, 0
Languishing over the 2018 market won’t do investors any good, but it is important to reflect on what made...
-
Target’s 2017 Ends As 2018 Begins: Reviewing Results & Guidance
Seth Golden, , Research Reports, 0
Earlier this month, Target released its Q4 2017 results alongside 2018 guidance. The release brought with it selling pressure...
-
-
Energy positive returns 6 consecutive months. Stick with Epicenter in 2H2021.
Seth Golden, , Research Reports, 0
STRATEGY: Stick with Epicenter in 2H2021. Strong markets stay strong. US COVID-19 deaths are “unvaccinated” Americans COVID-19 cases could...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00
Comments are closed.